MARILYN SULLIVAN: Open Payments
NPI 1003929373 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,798 in 46 payments from 10 companies in 2025. Trend: 2023 $559 · 2024 $1,049 · 2025 $1,798
Food & beverage: $1,798
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 15 | $578 |
| Lundbeck LLC | 13 | $349 |
| Otsuka America Pharmaceutical, Inc. | 2 | $215 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $209 |
| Neurocrine BioSciences, Inc. | 2 | $126 |
| Janssen Pharmaceuticals, Inc | 1 | $125 |
| ABBVIE INC. | 5 | $86 |
| Axsome Therapeutics, Inc. | 4 | $76 |
| Bausch Health US, LLC | 1 | $20 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: REXULTI, FANAPT, CAPLYTA, HETLIOZ, INGREZZA, SPRAVATO, VRAYLAR, Auvelity.
Industry payments across NY — which companies pay providers there.
